State Street’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-226,658
| Closed | -$4.17M | – | 4005 |
|
|
2020
Q4 | $4.17M | Sell |
226,658
-1,412
| -0.6% | -$26K | ﹤0.01% | 3052 |
|
|
2020
Q3 | $4.18M | Buy |
228,070
+3,752
| +2% | +$68.8K | ﹤0.01% | 2867 |
|
|
2020
Q2 | $3.36M | Buy |
224,318
+6,588
| +3% | +$98.6K | ﹤0.01% | 2958 |
|
|
2020
Q1 | $3.44M | Sell |
217,730
-11,236
| -5% | -$178K | ﹤0.01% | 2810 |
|
|
2019
Q4 | $3.72M | Buy |
228,966
+10,750
| +5% | +$175K | ﹤0.01% | 2988 |
|
|
2019
Q3 | $3.24M | Buy |
218,216
+5,153
| +2% | +$76.6K | ﹤0.01% | 3010 |
|
|
2019
Q2 | $3.52M | Buy |
213,063
+35,165
| +20% | +$581K | ﹤0.01% | 3002 |
|
|
2019
Q1 | $3.08M | Buy |
177,898
+6,184
| +4% | +$107K | ﹤0.01% | 2980 |
|
|
2018
Q4 | $3.03M | Buy |
171,714
+1,032
| +0.6% | +$18.2K | ﹤0.01% | 2944 |
|
|
2018
Q3 | $3.1M | Buy |
170,682
+29,018
| +20% | +$527K | ﹤0.01% | 3081 |
|
|
2018
Q2 | $2.77M | Buy |
141,664
+130,335
| +1,150% | +$2.55M | ﹤0.01% | 3127 |
|
|
2018
Q1 | $199K | Buy |
+11,329
| New | +$199K | ﹤0.01% | 3559 |
|
|
2017
Q2 | – | Sell |
-128,469
| Closed | -$1.52M | – | 3760 |
|
|
2017
Q1 | $1.52M | Buy |
128,469
+1,256
| +1% | +$14.8K | ﹤0.01% | 3182 |
|
|
2016
Q4 | $1.67M | Buy |
127,213
+8,328
| +7% | +$109K | ﹤0.01% | 3160 |
|
|
2016
Q3 | $1.72M | Buy |
118,885
+3,976
| +3% | +$57.7K | ﹤0.01% | 3029 |
|
|
2016
Q2 | $1.38M | Sell |
114,909
-2,229
| -2% | -$26.7K | ﹤0.01% | 3177 |
|
|
2016
Q1 | $2.19M | Buy |
117,138
+16,032
| +16% | +$299K | ﹤0.01% | 2974 |
|
|
2015
Q4 | $2.17M | Buy |
101,106
+11,340
| +13% | +$244K | ﹤0.01% | 2968 |
|
|
2015
Q3 | $1.52M | Buy |
89,766
+43,814
| +95% | +$741K | ﹤0.01% | 3099 |
|
|
2015
Q2 | $1.73M | Buy |
+45,952
| New | +$1.73M | ﹤0.01% | 3112 |
|